StockData
Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc. (CRBU) stock

CRBUNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3074% below fair value
$0.34−0.01 (-3.43%)

Close on Nov 17, 2026Market cap $36.53MP/E –Yield –

Caribou Biosciences total assets

Total assets on the balance sheet at the end of each period.

Caribou Biosciences's total assets was $142.77M at Jun 30, 2026. For fiscal 2025 it was $175.37M, down 44.0% from the year before. The highest annual figure on record is $442.36M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$175.37M-44.0%
FY2024Dec 31, 2024$313.31M-27.5%
FY2023Dec 31, 2023$432.21M+15.6%
FY2022Dec 31, 2022$373.77M-15.5%
FY2021Dec 31, 2021$442.36M+1127.2%
FY2020Dec 31, 2020$36.05M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$142.77M-35.4%
Q1 FY2026Mar 31, 2026$149.00M-45.6%
Q4 FY2025Dec 31, 2025$175.37M-44.0%
Q3 FY2025Sep 30, 2025$194.98M-43.4%
Q2 FY2025Jun 30, 2025$220.90M-40.8%
Q1 FY2025Mar 31, 2025$273.66M-32.7%
Q4 FY2024Dec 31, 2024$313.31M-27.5%
Q3 FY2024Sep 30, 2024$344.33M-24.7%
Q2 FY2024Jun 30, 2024$372.94M+6.7%
Q1 FY2024Mar 31, 2024$406.83M+17.1%
Q4 FY2023Dec 31, 2023$432.21M+15.6%
Q3 FY2023Sep 30, 2023$457.52M+14.7%
Q2 FY2023Jun 30, 2023$349.65M-17.0%
Q1 FY2023Mar 31, 2023$347.46M-22.1%
Q4 FY2022Dec 31, 2022$373.77M-15.5%
Q3 FY2022Sep 30, 2022$398.82M-13.7%
Q2 FY2022Jun 30, 2022$421.37M+166.0%
Q1 FY2022Mar 31, 2022$446.00M+1137.3%
Q4 FY2021Dec 31, 2021$442.36M–
Q3 FY2021Sep 30, 2021$461.96M–
Q2 FY2021Jun 30, 2021$158.40M–
Q4 FY2020Dec 31, 2020$36.05M–

More Caribou Biosciences figures

See a number that looks wrong?